NASDAQ : CMPS
-$0.01 (-0.07%)
2.89%
87
change: -121.0 | last: 20851
change: -73.0 | last: 12412
change: -17.0 | last: 2930
change: -24.0 | last: 54144
change: 116.0 | last: 2818200
11600
0.64
change: -247.9898 | last: 3.117345.04M
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | RTW Investments, LP | 12.97M | 9.90% |
| 2026-02-17 | AtaiBeckley Inc. | 4.76M | 4.96% |
| 2025-11-14 | Nantahala Capital Management, LLC | 3.48M | 3.57% |
| 2025-11-14 | Vivo Opportunity Fund Holdings, L.P. | 3.17M | 3.20% |
| 2025-10-29 | ATAI Life Sciences N.V. | 5.79M | 6.00% |
| 2025-08-14 | Nantahala Capital Management, LLC | 5.93M | 6.23% |
| 2025-08-14 | TCG Crossover GP I, LLC | 964.5K | 1.00% |
| 2025-08-14 | RTW Investments, LP | 9.47M | 9.90% |
| 2025-05-15 | Vivo Opportunity Fund Holdings, L.P. | 6.35M | 6.60% |
| 2025-05-15 | RTW Investments, LP | 7.88M | 8.30% |
| 2025-05-07 | Integrated Core Strategies (US) LLC | 1.95M | 2.10% |
| 2025-04-15 | George Jay Goldsmith | 2.24M | 2.40% |
| 2025-03-05 | ATAI Life Sciences N.V. | 6.91M | 7.50% |
| 2025-02-14 | Citadel Advisors LLC | 899.16K | 1.30% |
| 2025-02-13 | George Jay Goldsmith | 2.37M | 2.60% |
| 2025-02-06 | Integrated Core Strategies (US) LLC | 3.11M | 3.40% |
| 2025-01-17 | Deep Track Capital, LP | 9.27M | 9.99% |
| 2024-09-27 | ATAI Life Sciences AG | 6.91M | 10.10% |
| 2024-09-27 | ATAI Life Sciences N.V. | 6.91M | 10.10% |
| 2024-04-11 | Integrated Core Strategies (US) LLC | 3.88M | 5.70% |
| 2024-04-11 | Millennium Group Management LLC | 3.89M | 5.70% |
| 2024-04-11 | Millennium Management LLC | 3.89M | 5.70% |
| 2024-04-11 | Israel A. Englander | 3.89M | 5.70% |
| 2024-04-11 | Millennium Group Management LLC | 3.89M | 5.70% |
| 2024-04-11 | Millennium Management LLC | 3.89M | 5.70% |
| 2024-04-11 | Integrated Core Strategies (US) LLC | 3.88M | 5.70% |
| 2024-04-11 | Israel A. Englander | 3.89M | 5.70% |
| 2024-01-02 | 2. | 10.0 | 4.90% |
| 2024-01-02 | 2. | 10.0 | 5.00% |
| 2024-01-02 | Paradigm BioCapital Advisors LP | 3.43M | 5.40% |
| 2024-01-02 | 2. | 10.0 | 0.10% |
| 2024-01-02 | 2. | 10.0 | 4.90% |
| 2024-01-02 | 2. | 10.0 | 5.00% |
| 2024-01-02 | 2. | 10.0 | 0.10% |
| 2024-01-02 | 2. | 10.0 | 4.90% |
| 2024-01-02 | 2. | 10.0 | 4.90% |
| 2024-01-02 | 2. | 10.0 | 4.90% |
| 2024-01-02 | 2. | 10.0 | 0.10% |
| 2024-01-02 | 2. | 10.0 | 0.10% |
| 2024-01-02 | 2. | 10.0 | 0.10% |
| 2024-01-02 | 2. | 10.0 | 0.10% |
| 2024-01-02 | 2. | 10.0 | 4.90% |
| 2024-01-02 | Paradigm BioCapital Advisors LP | 3.43M | 5.40% |
| 2023-08-28 | TCG Crossover GP II, LLC | 5.79M | 8.90% |
| 2023-08-28 | TCG Crossover GP I, LLC | 1.93M | 3.10% |
| 2023-08-28 | TCG Crossover Fund I, L.P. | 1.93M | 3.10% |
| 2023-08-28 | Chen Yu | 6.44M | 9.90% |
| 2023-08-28 | Chen Yu | 6.44M | 9.90% |
| 2023-08-28 | TCG Crossover GP I, LLC | 1.93M | 3.10% |
| 2023-08-28 | TCG Crossover Fund I, L.P. | 1.93M | 3.10% |
| 2023-08-28 | TCG Crossover GP II, LLC | 5.79M | 8.90% |
| 2023-08-28 | TCG Crossover Fund II, L.P. | 5.79M | 8.90% |
| 2023-08-28 | TCG Crossover Fund II, L.P. | 5.79M | 8.90% |
| 2023-08-25 | Vivo Opportunity, LLC | 3.22M | 5.10% |
| 2023-08-25 | Vivo Opportunity Fund Holdings, L.P. | 3.22M | 5.10% |
| 2023-08-25 | Vivo Opportunity, LLC | 3.22M | 5.10% |
| 2023-08-25 | Vivo Opportunity Fund Holdings, L.P. | 3.22M | 5.10% |
| 2022-02-14 | The Founders Fund VII Management, LLC | 408.41K | 1.00% |
| 2022-02-14 | Peter Thiel | 1.31M | 3.10% |
| 2022-02-14 | Peter Thiel | 1.31M | 3.10% |
| 2022-02-14 | The Founders Fund VII Entrepreneurs Fund, LP | 3184.0 | 0.00% |
| 2022-02-14 | The Founders Fund VII, LP | 361.86K | 0.90% |
| 2022-02-14 | The Founders Fund VII Principals Fund, LP | 43363.0 | 0.10% |
| 2022-02-14 | Rivendell Investments 2017-9 LLC | 897.38K | 2.20% |
| 2021-12-02 | Logos Global Management GP LLC | 1.4M | 11.00% |
| 2021-12-02 | contained in this form are not required to respond unless the form displays a currently valid OMB co | 1.4M | 11.00% |
| 2021-12-02 | Arsani William | 1.4M | 11.00% |
| 2021-12-02 | Logos Global Master Fund LP | 1.4M | 11.00% |
| 2021-12-02 | Logos GP LLC | 1.4M | 11.00% |
| 2021-12-02 | contained in this form are not required to respond unless the form displays a currently valid OMB co | 1.4M | 11.00% |
| 2021-12-02 | Logos Global Management GP LLC | 1.4M | 11.00% |
| 2021-12-02 | Arsani William | 1.4M | 11.00% |
| 2021-12-02 | Logos Global Master Fund LP | 1.4M | 11.00% |
| 2021-12-02 | Logos GP LLC | 1.4M | 11.00% |
| 2021-12-01 | ATAI Life Sciences N.V. | 9.44M | 22.60% |
| 2021-12-01 | ATAI Life Sciences AG | 9.44M | 22.60% |
| 2021-11-29 | ATAI Life Sciences AG | 8.69M | 20.80% |
| 2021-11-29 | ATAI Life Sciences N.V. | 8.69M | 20.80% |
| 2021-05-24 | ATAI Life Sciences AG | 8.08M | 19.70% |
| 2021-05-24 | ATAI Life Sciences BV | 8.08M | 19.70% |
| 2021-02-16 | Peter Thiel | 2.35M | 6.50% |
| 2021-02-16 | Peter Thiel | 2.35M | 6.50% |
| 2021-02-16 | The Founders Fund VII, LP | 494.19K | 1.40% |
| 2021-02-16 | The Founders Fund VII, LP | 494.19K | 1.40% |
| 2021-02-16 | The Founders Fund VII Principals Fund, LP | 59218.0 | 0.20% |
| 2021-02-16 | The Founders Fund VII Management, LLC | 557.76K | 1.60% |
| 2021-02-16 | Rivendell Investments 2017-9 LLC | 1.79M | 5.00% |
| 2021-02-16 | The Founders Fund VII Management, LLC | 557.76K | 1.60% |
| 2021-02-16 | LP | 4352.0 | 0.00% |
| 2021-02-16 | LP | 4352.0 | 0.00% |
| 2021-02-16 | The Founders Fund VII Principals Fund, LP | 59218.0 | 0.20% |
| 2021-02-16 | Rivendell Investments 2017-9 LLC | 1.79M | 5.00% |
| 2021-02-12 | Ekaterina Malievskaia | 4.52M | 12.60% |
| 2021-02-12 | George Jay Goldsmith | 4.52M | 12.60% |
| 2021-02-12 | George Jay Goldsmith | 4.52M | 12.60% |
| 2021-02-12 | Ekaterina Malievskaia | 4.52M | 12.60% |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $6.90 | 93.5M | $645.18M | $149.61M | $20.92M | $516.5M |
| 2024-12-31 | $3.78 | 67.48M | $255.09M | $165.08M | $32.19M | $122.2M |
| 2023-12-31 | $8.75 | 51.03M | $446.5M | $220.2M | $33.05M | $259.35M |
| 2022-12-31 | $8.03 | 42.44M | $340.76M | $143.21M | $1.93M | $199.49M |
| 2021-12-31 | $22.10 | 40M | $883.95M | $273.24M | $3.61M | $614.32M |
| 2020-12-31 | $47.64 | 35.93M | $1.71B | $190.33M | -$ | $1.52B |
| 2019-12-31 | $29.00 | 21.72M | $630.01M | $24.97M | $21.09M | $626.14M |
| 2018-12-31 | $29.00 | 5.62M | $162.95M | $22.91M | -$ | $140.04M |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14.15 | 135.04M | $1.91B | $433.3M | $54.63M | $1.53B |
| 2026-03-31 | $5.53 | 110.06M | $608.66M | $466.01M | $2.83M | $145.48M |
| 2025-12-31 | $6.90 | 93.64M | $646.09M | $149.61M | $35.04M | $531.52M |
| 2025-09-30 | $5.73 | 95.34M | $546.29M | $185.94M | $35.18M | $395.53M |
| 2025-06-30 | $2.80 | 93.34M | $261.36M | $221.88M | $35.29M | $74.76M |
| 2025-03-31 | $2.86 | 89.19M | $255.09M | $260.11M | $32.03M | $27.01M |
| 2024-12-31 | $3.78 | 68.47M | $258.8M | $165.08M | $32.19M | $125.91M |
| 2024-09-30 | $6.30 | 68.4M | $430.89M | $206.95M | $32.55M | $256.49M |
| 2024-06-30 | $5.95 | 68.37M | $406.81M | $228.63M | $32.62M | $210.8M |
| 2024-03-31 | $9.68 | 64.22M | $621.67M | $262.89M | $32.81M | $391.59M |
| 2023-12-31 | $8.75 | 61.96M | $542.16M | $220.2M | $33.05M | $355.02M |
| 2023-09-30 | $7.40 | 49.63M | $367.28M | $248.04M | $32.53M | $151.78M |